MR-proADM as prognostic factor of outcome in COVID-19 patients

MR-proADM as prognostic factor of outcome in COVID-19 patients

Abstract Mid Regional pro-ADM (MR-proADM) is a promising novel biomarker in the evaluation of deteriorating patients and an emergent prognosis factor in patients with sepsis, septic shock and organ failure. It can be induced by bacteria, fungi or viruses. We hypothesized that the assessment of MR-pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emanuela Sozio, Carlo Tascini, Martina Fabris, Federica D’Aurizio, Chiara De Carlo, Elena Graziano, Flavio Bassi, Francesco Sbrana, Andrea Ripoli, Alberto Pagotto, Alessandro Giacinta, Valentina Gerussi, Daniela Visentini, Paola De Stefanis, Maria Merelli, Kordo Saeed, Francesco Curcio
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/a8a013a15cbd41c2a6ba4ba6f7e62b67
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares